Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures
Vivek Subbiah(The University of Texas MD Anderson Cancer Center), Razelle Kurzrock(Medical College of Wisconsin)
Cited by 69
Related Papers
Epstein-Barr Virus and Cancer
|Clinical Cancer Research|2004|795
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
|Nature Medicine|2019|710
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study
|Journal of Clinical Oncology|2018|500
PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring <i>PIK3CA</i> Mutations
|Journal of Clinical Oncology|2012|451